| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,430,000,000 |
| Market
Cap: |
97.41(B) |
| Last
Volume: |
6,619,168 |
Avg
Vol: |
8,474,413 |
| 52
Week Range: |
$48.64 - $68.84 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 297 |
| Guru Rank Value : 4.1 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
86,763 |
367,796 |
891,893 |
1,873,129 |
| Total Sell Value |
$5,815,387 |
$21,391,604 |
$49,075,093 |
$91,423,659 |
| Total People Sold |
6 |
8 |
11 |
13 |
| Total Sell Transactions |
9 |
19 |
36 |
71 |
| End Date |
2024-01-18 |
2023-10-17 |
2023-04-18 |
2022-04-18 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Johnson Kristina M |
Director |
• • – |
2014-10-31 |
4 |
A |
$0.00 |
$0 |
D/D |
13,177 |
16,301 |
|
- |
|
| Reinhardt Uwe E |
Director |
• • – |
2014-10-31 |
4 |
A |
$0.00 |
$0 |
D/D |
13,177 |
159,379 |
|
- |
|
| Connors Nelda J |
Director |
• • – |
2014-10-31 |
4 |
A |
$0.00 |
$0 |
D/D |
13,177 |
13,177 |
|
- |
|
| Byrnes Bruce L |
Director |
• • – |
2014-10-31 |
4 |
A |
$0.00 |
$0 |
D/D |
13,177 |
112,097 |
|
- |
|
| Nicholas Peter M |
Director |
• • – |
2014-10-31 |
4 |
A |
$0.00 |
$0 |
D/D |
21,083 |
3,458,578 |
|
- |
|
| Mario Ernest |
Director |
• • – |
2014-10-08 |
4 |
AS |
$12.06 |
$120,600 |
D/D |
(10,000) |
267,855 |
|
- |
|
| Mario Ernest |
Director |
• • – |
2014-09-02 |
4 |
AS |
$12.60 |
$125,992 |
D/D |
(10,000) |
277,855 |
|
- |
|
| Nicholas Nicholas J Jr |
Director |
• • – |
2014-08-19 |
4 |
D |
$0.00 |
$0 |
I/I |
(8,000) |
0 |
|
- |
|
| Phalen Michael P. |
EVP & President, MedSurg |
• • – |
2014-08-15 |
4 |
AS |
$12.58 |
$144,305 |
D/D |
(11,471) |
127,486 |
|
- |
|
| Phalen Michael P. |
EVP & President, MedSurg |
• • – |
2014-08-15 |
4 |
OE |
$7.41 |
$87,473 |
D/D |
11,471 |
138,957 |
|
- |
|
| Mario Ernest |
Director |
• • – |
2014-08-01 |
4 |
AS |
$12.58 |
$125,817 |
D/D |
(10,000) |
287,855 |
|
- |
|
| Pierce David A |
SVP and President, Endoscopy |
• • – |
2014-07-30 |
4 |
AS |
$12.97 |
$2,036 |
D/D |
(157) |
43,161 |
|
- |
|
| Pierce David A |
SVP and President, Endoscopy |
• • – |
2014-07-28 |
4 |
D |
$12.97 |
$999 |
D/D |
(77) |
43,318 |
|
- |
|
| Pierce David A |
SVP and President, Endoscopy |
• • – |
2014-07-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
234 |
43,395 |
|
- |
|
| Phalen Michael P. |
EVP & President, MedSurg |
• • – |
2014-07-15 |
4 |
AS |
$13.04 |
$879,998 |
D/D |
(67,500) |
127,486 |
|
- |
|
| Phalen Michael P. |
EVP & President, MedSurg |
• • – |
2014-07-15 |
4 |
OE |
$7.41 |
$520,200 |
D/D |
67,500 |
194,986 |
|
- |
|
| Prange Karen |
SVP&Pres, Uro & Womens Health |
• • – |
2014-07-02 |
4 |
D |
$13.13 |
$110,541 |
D/D |
(8,419) |
37,183 |
|
- |
|
| Prange Karen |
SVP&Pres, Uro & Womens Health |
• • – |
2014-07-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,862 |
45,602 |
|
- |
|
| Mario Ernest |
Director |
• • – |
2014-07-01 |
4 |
AS |
$12.95 |
$129,468 |
D/D |
(10,000) |
297,855 |
|
- |
|
| Phalen Michael P. |
EVP & President, MedSurg |
• • – |
2014-06-16 |
4 |
AS |
$13.02 |
$175,829 |
D/D |
(13,500) |
127,486 |
|
- |
|
| Phalen Michael P. |
EVP & President, MedSurg |
• • – |
2014-06-16 |
4 |
OE |
$7.41 |
$104,040 |
D/D |
13,500 |
140,986 |
|
- |
|
| Mario Ernest |
Director |
• • – |
2014-06-02 |
4 |
AS |
$12.88 |
$128,790 |
D/D |
(10,000) |
307,855 |
|
- |
|
| Phalen Michael P. |
EVP & President, MedSurg |
• • – |
2014-05-15 |
4 |
AS |
$12.76 |
$172,206 |
D/D |
(13,500) |
127,486 |
|
- |
|
| Phalen Michael P. |
EVP & President, MedSurg |
• • – |
2014-05-15 |
4 |
OE |
$7.41 |
$104,040 |
D/D |
13,500 |
140,986 |
|
- |
|
| Mario Ernest |
Director |
• • – |
2014-05-01 |
4 |
AS |
$12.58 |
$125,836 |
D/D |
(10,000) |
317,855 |
|
- |
|
2007 Records found
|
|
Page 9 of 81 |
|
|
0.68 (1.01%) 
